Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
07/20/2010 | CA2407866C Process for the synthesis of amine ethers from secondary amino oxides |
07/20/2010 | CA2399001C Integrin expression inhibitor |
07/15/2010 | WO2010080481A1 Carbazole carboxamide compounds useful as kinase inhibitors |
07/15/2010 | WO2010080474A1 Carbazole and carboline kinase inhibitors |
07/15/2010 | WO2010079675A1 Method for manufacturing bicyclic aromatic hydroxycarboxylic acid |
07/15/2010 | WO2010001167A3 Preparation of 3-pyrrole substituted 2-indolinone derivatives |
07/15/2010 | US20100179332 Process for the purification of ropinirole hydrochloride |
07/15/2010 | US20100179326 Benzamide derivative |
07/15/2010 | US20100179325 Compound having 11beta-hsd1 inhibitory activity |
07/15/2010 | US20100179207 Compounds |
07/15/2010 | US20100179145 Pharmaceutical combinations |
07/15/2010 | US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors |
07/15/2010 | CA2747670A1 Carbazole carboxamide compounds useful as kinase inhibitors |
07/14/2010 | EP2206716A1 Host material for light-emitting diodes |
07/14/2010 | EP2206698A1 Ethynylindole compounds |
07/14/2010 | EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors |
07/14/2010 | EP2205559A1 Renin inhibitors |
07/14/2010 | EP1652892B1 Cyanine compounds, optical recording materials and optical recording media |
07/14/2010 | EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
07/14/2010 | EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
07/14/2010 | CN1914170B Synthetic methodology for the reductive alkylation at the c-3 position of indoles |
07/14/2010 | CN101778906A Indolium compound and optical recording material using the compound |
07/14/2010 | CN101778819A Indole indane amide compounds useful as cb2 agonists and method |
07/14/2010 | CN101775357A Plant pathogenic fungi fusarium moniliforme natural antagonist |
07/14/2010 | CN101775010A Carbazole-terminated heterofluorene main body material and preparation and application method |
07/14/2010 | CN101775007A Tricyclene compounds with HIV antagonistic activity and preparation method and application thereof |
07/14/2010 | CN101774962A Preparation method of compound 2-(1,3-dicarbonyl Isoindoline-2-yl)-3-substituted propane-2-olefine acid |
07/14/2010 | CN101774961A Compound having affinity with progeria dementia A beta plaques, preparation method and application thereof |
07/14/2010 | CN101774960A Preparation method of (2S)-indoline-2-methanoic acid |
07/14/2010 | CN101774959A Preparation method and application of bromine-containing indole alkaloid |
07/14/2010 | CN101774879A Method for simultaneously extracting high-purity beta-methylnaphthalene and indole from coal tar |
07/14/2010 | CN101245047B Purification method for tryptophane |
07/13/2010 | USRE41439 Pharmaceutical compositions and methods for use |
07/13/2010 | US7754896 Indol-alanine derivatives as selective S1P4-agonists |
07/13/2010 | US7754895 Process for the synthesis of progesterone receptor modulators |
07/13/2010 | US7754894 Crystalline sulfonamide-containing indole compound and process for preparing the same |
07/13/2010 | US7754893 Conjugates of biological substances |
07/13/2010 | US7754886 N-acylsulfonamide apoptosis promoters |
07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
07/13/2010 | US7754771 Compounds for the treatment of AIDS and other viral diseases |
07/13/2010 | US7754756 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder |
07/13/2010 | US7754755 Inhibitors of 15-lipoxygenase |
07/13/2010 | US7754740 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong |
07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
07/13/2010 | US7754725 (2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(2-dimethylamino-ethoxy)-1,3-dihydro-isoindol-2-yl]-methanone; inhibits or modulates activity of heat shock protein Hsp90; useful for treating cancer, particularly hematopoietic tumors of lymphoid or myeloid lineage, prostate, lung, breast cancer, melanoma |
07/13/2010 | US7754654 Substituted spirocyclic ketoenols |
07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
07/13/2010 | CA2352066C Process for the preparation of derivatized polymers |
07/08/2010 | WO2010077839A1 Substituted oxindol cb2 agonists for pain treatment |
07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
07/08/2010 | WO2010076566A2 Indoles useful in the treatment of inflammation |
07/08/2010 | WO2009147031A3 Oxime ester photoinitiators |
07/08/2010 | US20100174095 Organic compound, semiconductor film electrode employing the organic compound, photoelectric conversion element employing the organic compound, and photoelectrochemical solar cell employing the organic compound |
07/08/2010 | US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia |
07/08/2010 | US20100174084 2-Alkoxy-6-alkyl-phenyl-substituted Spirocyclic Tetramic Acid Derivatives |
07/08/2010 | US20100174077 Processes and intermediates |
07/08/2010 | US20100174075 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension |
07/08/2010 | US20100173993 Controlled release biocidal salts |
07/08/2010 | US20100173968 Sub-type selective azabicycloalkane derivatives |
07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
07/08/2010 | US20100173849 Neo-tryptophan |
07/08/2010 | US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
07/08/2010 | US20100170418 Complexes of carbon nanotubes and fullerenes with molecular-clips and use thereof |
07/08/2010 | CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same |
07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
07/07/2010 | EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
07/07/2010 | EP2203423A1 Indoline compounds |
07/07/2010 | CN101768118A Bi-imidazoline diphenylamine compound and preparation method thereof |
07/07/2010 | CN101768090A Organic light-emitting material 4,4 '-bis-arylation acetenyl azobenzol compound, synthesis method and application |
07/06/2010 | US7750163 Cyanine dye labelling reagents |
07/06/2010 | US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects |
07/06/2010 | US7750038 1-methyl-5-[1-(methylsulfonyl)-2,3-dihydro-1H-indol-5-yl]-1H-pyrrole-2-carbonitrile; contraception; fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, and hormone-dependent carcinomas; providing hormone replacement therapy; stimulating food intake |
07/06/2010 | US7750036 Carvedilol salts, corresponding compositions, methods of delivery and/or treatment |
07/06/2010 | US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection |
07/06/2010 | CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
07/01/2010 | WO2010075064A1 Triple reuptake inhibitors and methods of their use |
07/01/2010 | WO2010074779A1 Oxidation of alkylaromatic compounds |
07/01/2010 | WO2010074520A2 Novel organic semiconductor compound, method for preparing same, and organic semiconductor composition, and organic semiconductor thin film and element containing same |
07/01/2010 | WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe |
07/01/2010 | WO2010073857A1 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound |
07/01/2010 | WO2010073719A1 Eg5 inhibitor |
07/01/2010 | WO2010073253A1 Method for preparing an optically active frovatriptan |
07/01/2010 | WO2010072144A1 Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof |
07/01/2010 | WO2010021693A3 Mif modulators |
07/01/2010 | US20100168441 Process for production of substituted benzene |
07/01/2010 | US20100168440 Homogeneous Asymmetric Hydrogenation Process |
07/01/2010 | US20100168429 Transition metal catalyzed synthesis of N-aminoindoles |
07/01/2010 | US20100168413 One-pot synthesis of benzisoindolenines used in the preparation of naphthalocyanines |
07/01/2010 | US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
07/01/2010 | US20100168096 Acylguanidine derivative or salt thereof |
07/01/2010 | US20100167995 Peptoid compounds |
07/01/2010 | US20100167994 Targeting of ews-fli1 as anti-tumor therapy |
07/01/2010 | US20100167927 Substituted Amino-Thiourea Compounds For Combating Animal Pests |
07/01/2010 | US20100167333 Heavy Metal Binding Compounds and Their Method of Use |
07/01/2010 | US20100166881 Novel IDO Inhibitors and Methods of Use Thereof |
07/01/2010 | US20100163852 Material for light-emitting device and light-emitting device |
07/01/2010 | CA2772760A1 Small molecule inhibitors of necroptosis |
07/01/2010 | CA2747784A1 Pharmaceutical compounds |
07/01/2010 | CA2746055A1 Triple reuptake inhibitors and methods of their use |
06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |